POTACHLORIDE PR 750:Uses , Side effect, Dosage, Pictuers, ETC.....

POTACHLORIDE PR 750

prolonged Release Potassium Chloride B.P 750 mg

POTACHLORIDE PR 750 B.P 750 mg, commonly referred to as Prolonged Release Potassium Chloride   , is a pharmaceutical formulation designed to deliver potassium chloride in a sustained manner. This article delves into the significance and advantages of POTACHLORIDE PR 750 in clinical practice.

Exploring POTACHLORIDE PR 750:

• Formulation: POTACHLORIDE PR 750 encapsulates potassium chloride within a specialized matrix, facilitating controlled release of the active ingredient over an extended duration.
• Mechanism of Action: The prolonged release mechanism ensures gradual dissolution and absorption of potassium ions in the gastrointestinal tract, thereby minimizing fluctuations in serum potassium levels.
• Indications: POTACHLORIDE PR 750 is indicated for the prevention and treatment of hypokalemia, a condition characterized by deficient potassium levels in the bloodstream.

Key Benefits of POTACHLORIDE PR 750:

• Stable Serum Potassium Levels: The sustained release profile of POTACHLORIDE PR 750 helps maintain steady-state serum potassium concentrations, reducing the risk of sudden spikes or drops.
• Enhanced Patient Compliance: With once-daily dosing, POTACHLORIDE PR 750 offers convenience and simplicity, promoting better adherence to prescribed treatment regimens.
• Minimized Gastrointestinal Disturbances: Compared to immediate-release formulations, POTACHLORIDE PR 750 is associated with a lower incidence of gastrointestinal side effects, owing to its gradual absorption profile.

Administration and Dosage Guidelines:

• Dosage Regimen: The recommended dosage of POTACHLORIDE PR 750 is typically determined based on individual potassium requirements and response to therapy.
• Administration Protocol: POTACHLORIDE PR 750 tablets should be swallowed whole with a sufficient amount of water, preferably with meals to minimize gastric irritation.
• Monitoring Parameters: Healthcare providers may monitor serum potassium levels periodically to assess treatment efficacy and adjust dosage as necessary.

Safety Considerations and Precautions:

• Renal Impairment: Patients with impaired renal function require close monitoring when using POTACHLORIDE PR 750, as excessive potassium accumulation may occur.
• Concomitant Medications: Certain medications, such as potassium-sparing diuretics or ACE inhibitors, may potentiate the effects of POTACHLORIDE PR 750, necessitating dose adjustments or monitoring for hyperkalemia.

Conclusion: Prolonged Release Potassium Chloride B.P 750 mg, marketed as POTACHLORIDE PR 750, represents a significant advancement in potassium supplementation therapy. Through its unique formulation and sustained release mechanism, POTACHLORIDE PR 750 offers a reliable solution for maintaining optimal serum potassium levels and addressing potassium deficiency-related disorders, thereby improving patient outcomes and quality of life.A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology. 

For further information: EMAIL:  info@sterispharma.com  / contact@sterispharma.com    

CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668 

BUY NOW